A randomized, double-blind, placebo-controlled phase 1 trial of the topical pan–lysyl oxidase inhibitor PXS-6302 in mature scars

Journal:

Science Translational Medicine

Published:

2025-09-10

DOI:

10.1126/scitranslmed.adv2471

Affiliations:

9

Authors:

13

Go to article

Institutions	Authors	Share
The University of Western Australia (UWA), Australia	4.333333	0.33
Syntara Ltd., Australia	4.000000	0.31
Fiona Stanley Hospital (FSH), Australia	3.666667	0.28
MOE Key Laboratory for Biomedical Engineering, ZJU, China	0.333333	0.03
Queen Elizabeth II Medical Centre (QEIIMC), UWA, Australia	0.333333	0.03
Nicolaus Copernicus University in Toruń (NCU), Poland	0.333333	0.03

Interested in Clinical Sciences?